http://www.solvingdiabetes.org/2009/10/25/report-from-ipitaixa-2009-joint-meeting/ A site dedicated to solving diabetes. Sat, 14 Aug 2010 23:12:33 +0000 http://wordpress.org/?v=2.9.2 hourly 1 http://www.solvingdiabetes.org/2009/10/25/report-from-ipitaixa-2009-joint-meeting/comment-page-1/#comment-341 Scott King Tue, 03 Nov 2009 16:07:41 +0000 http://www.solvingdiabetes.org/?p=576#comment-341 <b>Mr. King, Quick question. Do you do any collaboration with LCT? Seems to me that you are both researching the same technology (encapsulating) but I don't see any interaction between the two companies. Also, it seems they are much further along on trails. Does this stem from US laws hindering efforts within the US? Omar Perez </b> Omar-- You can see proto-interaction between LCT and Cerco above: the second photo shows Bob Elliott and me talking at our reception at the IPITA conference. Bob and I have always gotten along well; last year he invited me to speak at the LCT Science Advisory Board meeting in Auckland. You are quite right; it makes sense for LCT and Cerco to cooperate. The time is not yet ripe. We expect that the Islet Sheet will (1) be retrievable and replaceable, making the Sheet safer than microcapsules, and (2) will support greater functionality from each islet. The latter means that a smaller number of islets would be required using the Islet Sheet capsule. Clearly LCT would benefit if we are right. The Hanuman Medical Foundation grant means we have the funds to determine the safety and efficacy of the Islet Sheet at UC Irvine using the best characterized models of islet transplantation. Once we have solid results from those studies we would want to begin collaborative studies using LCT's pig islets in our sheets. LCT is aware of this. Scott King Mr. King,
Quick question. Do you do any collaboration with LCT? Seems to me that you are both researching the same technology (encapsulating) but I don’t see any interaction between the two companies. Also, it seems they are much further along on trails. Does this stem from US laws hindering efforts within the US?
Omar Perez

Omar–
You can see proto-interaction between LCT and Cerco above: the second photo shows Bob Elliott and me talking at our reception at the IPITA conference. Bob and I have always gotten along well; last year he invited me to speak at the LCT Science Advisory Board meeting in Auckland.
You are quite right; it makes sense for LCT and Cerco to cooperate. The time is not yet ripe. We expect that the Islet Sheet will (1) be retrievable and replaceable, making the Sheet safer than microcapsules, and (2) will support greater functionality from each islet. The latter means that a smaller number of islets would be required using the Islet Sheet capsule. Clearly LCT would benefit if we are right.
The Hanuman Medical Foundation grant means we have the funds to determine the safety and efficacy of the Islet Sheet at UC Irvine using the best characterized models of islet transplantation. Once we have solid results from those studies we would want to begin collaborative studies using LCT’s pig islets in our sheets. LCT is aware of this.
Scott King

]]>